Mon, September 18, 2017
Fri, September 15, 2017
Thu, September 14, 2017

Brian Abrahams Initiated (BIIB) at Hold and Held Target at $319 on, Sep 15th, 2017

Brian Abrahams of RBC Capital, Initiated "Biogen Inc." (BIIB) at Hold and Held Target at $319 on, Sep 15th, 2017.

Brian has made no other calls on BIIB in the last 4 months.



There are 6 other peers that have a rating on BIIB. Out of the 6 peers that are also analyzing BIIB, 4 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jeffrey Silber of "BMO Capital" Maintained at Hold with Increased Target to $377 on, Wednesday, September 13th, 2017
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $311 on, Wednesday, July 26th, 2017
  • Carter Gould of "UBS" Maintained at Hold with Increased Target to $285 on, Wednesday, July 26th, 2017
  • Eun Yang of "Jefferies" Initiated at Hold and Held Target at $310 on, Tuesday, July 11th, 2017


These are the ratings of the 2 analyists that currently disagree with Brian


  • Terence Flynn of "Goldman Sachs" Upgraded at Strong Buy on, Wednesday, August 16th, 2017
  • Andrew Peters of "Deutsche Bank" Initiated at Strong Buy and Held Target at $315 on, Friday, June 23rd, 2017